New Key Statistics Module, Z-Score and F-Score
SZSE:300436 Key Ratios
Market Cap ¥ M | 2,780.80 |
Enterprise Value ¥ M | 3,055.52 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 5.54 |
Price/Sales | 6.12 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 454.00 |
EPS (TTM) ¥ | -1.88 |
Beneish M-Score | -2.84 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -15.66 |
EV-to-EBITDA | -15.66 |
PEG | -- |
Shares Outstanding M | 159.27 |
Net Margin (%) | -65.99 |
Operating Margin % | -29.30 |
Pre-tax Margin (%) | -51.08 |
Quick Ratio | 0.57 |
Current Ratio | 0.79 |
ROA % (ttm) | -17.93 |
ROE % (ttm) | -46.79 |
ROIC % (ttm) | -12.49 |
Dividend Yield % | -- |
Altman Z-Score | 1.18 |
SZSE:300436 Number of Guru Trades
SZSE:300436 Volume of Guru Trades
Gurus Latest Trades with SZSE:300436
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300436 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fujian Cosunter Pharmaceutical Co Ltd Insider Transactions
No Available Data